New product: Noxafil (posaconazole) 100 mg Gastro-resistant Tablets -

New product: Noxafil (posaconazole) 100 mg Gastro-resistant Tablets
Information type: Drug prescribing
Source: Glenmark Pharmaceuticals Europe Ltd
Specialities: Infection and infectious diseases
Summary
Noxafil® gastro-resistant tablets are indicated for use in the treatment of a number of fungal infections in adults, and for the prophylaxis of invasive fungal infections in certain patients receiving remission-induction chemotherapy for AML or MDS, and certain HSCT recipients.
UKMi comment
Posaconazole was previously only available in the UK in a liquid formulation (Noxafil® oral suspension; 200mg/5mL).
Related links: